World News | Amid Vaccine Certification Issue, National Health Authority CEO Calls for Deepening India-UK Health Ties

Get latest articles and stories on World at LatestLY. After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma has said that he looks forward to deepening ties between the health bodies of the two countries.

National Health Authority's CEO Dr RS Sharma

New Delhi [India], September 23 (ANI): After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma on Thursday said that he looks forward to deepening ties between the health bodies of the two countries.

The meeting came amid the rising concerns over the new travel rules issued by the UK.

Also Read | Type-C Charger for All! EU Law To Force All Portable Electronic Devices and Mobile Phones Including iPhones To Have USB-C Port To Cut E-Waste.

Dr Sharma said that the meeting will be instrumental in resuming socio-economic ties between the two countries.

"Echoing his excellency @AlexWEllis's views, this will be instrumental in resuming socio-economic activities between India and UK. We also look forward to deepening ties between @AyushmanNHA and @NHSX, as we collaborate to build a digital continuum of healthcare services," Dr Sharma said in a tweet.

Also Read | PM Narendra Modi US Visit Schedule: From QUAD Summit to Meeting With Joe Biden and UNGA Address, Know Day-Wise Itinerary As per India Time.

Earlier, Ellis said the "excellent discussions" were an important step forward in "our joint aim to facilitate travel and fully protect the public health of UK and India".

"Excellent technical discussions with @rssharma3 @AyushmanNHA. Neither side raised technical concerns with each other's certification process. An important step forward in our joint aim to facilitate travel and fully protect public health of UK and India," Ellis tweeted.

The UK issued a revised travel advisory on Wednesday and said that Covishield is qualified as an approved vaccine.

It approved individuals with a full course of the Oxford-AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan. But the list does not include India. This advisory will be applicable from 4 am (local time) on October 4. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now